Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy
暂无分享,去创建一个
Tevfik F Ismail | Dudley J Pennell | Sanjay K Prasad | D. Pennell | T. Ismail | S. Prasad | S. Prasad
[1] W. Roberts,et al. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.
[2] F. Harrell,et al. Regression models for prognostic prediction: advantages, problems, and suggested solutions. , 1985, Cancer treatment reports.
[3] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[4] B. Maron,et al. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.
[5] G. Kay,et al. Rate-modulated cardiac pacing based on transthoracic impedance measurements of minute ventilation: correlation with exercise gas exchange. , 1989, Journal of the American College of Cardiology.
[6] J. Concato,et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.
[7] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[8] W. Mckenna,et al. Prognosis of idiopathic dilated cardiomyopathy. , 1995, Journal of cardiac failure.
[10] W. Roberts,et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.
[11] H. Watkins. Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[12] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[13] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[14] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[15] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.
[16] D. Pennell,et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I , 2005, Heart.
[17] F. Ridocci,et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.
[18] B. Maron,et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.
[19] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[20] J. Olgin,et al. Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure , 2006, Circulation.
[21] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .
[22] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[23] Warren J Manning,et al. Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.
[24] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[25] O. Rimoldi,et al. Stunning, Hibernation, and Assessment of Myocardial Viability , 2008, Circulation.
[26] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[27] W. Roberts,et al. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. , 2008, The American journal of cardiology.
[28] R. Bonamini,et al. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features. , 2009, Circulation Cardiovascular Imaging.
[29] S. Colan,et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. , 2010, The New England journal of medicine.
[30] Dudley J. Pennell,et al. Cardiovascular Magnetic Resonance , 2010, Circulation.
[31] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[32] H. Katus,et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy , 2010, Heart.
[33] A. Tajik,et al. Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[34] G. Bonsel,et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[35] Stefan O Schoenberg,et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[36] M. Cheitlin,et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .
[37] B. Funke,et al. Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.